Summary The nature of neoplasia and its sometime end result, cancer, has been studied by exposition and explanation of the sequential lesions of tumour progression. Neoplastic lesions were divided into four classes on the basis of growth characterisitcs and whether lesional growth is confined to one The induction of a neoplastic system does not result in cancer as the initial lesion, with rare exceptions. At the outset, the lesions produced by carcinogens are not cancer but focal proliferations that are orderly in form and temporally restricted in their growth; benign tumours in classical nosology. If other lesions, with abnormal form and cytology as compared with the initial lesion, are to appear they follow the initial lesion. If a lesion with the biological properties of primary cancer is to appear, it usually does so only after at least one half of the life span of the affected subject has passed. The sequential lesional events between induction and cancer, including metastases, may be encompassed by the term tumour progression; the subject of this paper. The development of cancer seems to be similar, though not precisely identical, in all neoplastic systems. The concepts presented are based upon the personal study, over a period of some 25 years, of all of the sequential lesions of human melanocytic neoplasia and a comparison of the observed phenomena with some other forms of neoplasia. What I have attempted to do is to describe the classes of lesions seen in neoplatic development based upon the behaviour (life history) of the various lesions. Next, I have presented, without explanation, the lesional classes as illustrated by human melanocytic neoplasia. These classes are then compared with other neoplastic systems. Finally, I have attempted explanation and formulation of a conceptual framework for the nature of cancer based upon these observations of cancer development. The conclusions derived about the nature of cancer are pluralistic and are not considered as due to some discrete change in a cell, whose progeny, as a result of that discrete change, carries all of the information required to explain the almost limitless events of a neoplastic system.
The induction of a neoplastic system does not result in cancer as the initial lesion, with rare exceptions. At the outset, the lesions produced by carcinogens are not cancer but focal proliferations that are orderly in form and temporally restricted in their growth; benign tumours in classical nosology. If other lesions, with abnormal form and cytology as compared with the initial lesion, are to appear they follow the initial lesion. If a lesion with the biological properties of primary cancer is to appear, it usually does so only after at least one half of the life span of the affected subject has passed. The sequential lesional events between induction and cancer, including metastases, may be encompassed by the term tumour progression; the subject of this paper. The development of cancer seems to be similar, though not precisely identical, in all neoplastic systems. The concepts presented are based upon the personal study, over a period of some 25 years, of all of the sequential lesions of human melanocytic neoplasia and a comparison of the observed phenomena with some other forms of neoplasia. What I have attempted to do is to describe the classes of lesions seen in neoplatic development based upon the behaviour (life history) of the various lesions. Next, I have presented, without explanation, the lesional classes as illustrated by human melanocytic neoplasia. These classes are then compared with other neoplastic systems. Finally, I have attempted explanation and formulation of a conceptual framework for the nature of cancer based upon these observations of cancer development. The conclusions derived about the nature of cancer are pluralistic and are not considered as due to some discrete change in a cell, whose progeny, as a result of that discrete change, carries all of the information required to explain the almost limitless events of a neoplastic system.
The Pigmented Lesion Study Group of the University of Pennsylvania has studied tumour progression in melanocytic neoplasia since 1 September 1972. We have studied 2,383 patients with melanoma through 31 December 1990. For each patient, 343 clinical and pathology attributes have been recorded and computerised. Features such as the number and kinds of melanocytic nevi and the detailed pathology of the primary melanomas have been investigated. We have followed our patients prospectively and <2% have been lost to follow-up. Such follow-up has permitted us to document the behaviour and biologic significance of the various lesions of tumour progression. Details of the methodology have been previously published (Clark et al., 1984 (Clark et al., , 1989 . We have photographed the entire skin of all patients since 1 May 1976. The presence of pigmented lesions, affording excellent visibility, on the body surface makes it possible to document the macroscopic events (and their microscopic corollaries) of tumour progression in this paradigmatic neoplastic system. In no other neoplastic system, human or experimental, is this so readily accomplished. Perhaps, in no other system is this possible. Here, the results of our studies are compared with experimental hepatocarcinogenesis and cutaneous carcinogenesis, as well as with human keratinocytic and colonic neoplasia. Other neoplastic systems, carcinoma of the cervix, for instance, are apparently similar. The correspondencies between the different neoplastic systems suggest the unifying hypothesis that tumour progression is the dominant biologic phenomenon linking the diverse kinds of neoplasia into a single disease entity.
Definitions
The lack of understanding of the basic biology of neoplasia has resulted in different definitions of even its most fundamental terms. The following definitions permit the reader to understand how we use terms essential to discussions of neoplastic biology (Clark, 1991) .
Cancer is a population of abnormal cells showing temporally unrestricted growth preference (continually increasing numbers of cells in the population) over their normal counterparts. Such abnormal cells invade surrounding tissues, traverse at least one basement membrane zone, grow in the mesenchyme at the primary site, and may metastasise to distant sites. It is the totality of properties, not any one property, that determines whether or not a given lesion should be designated as a cancer. (Morikawa et al., 1988; Zetter, 1990 (Schmoeckel et al., 1989; Lea & Pawlowski, 1986; Yaar et al., 1988) ; traverse of the basement membrane zone is not accomplished by lysis of that zone, as in 'malignant' traverse of a basement membrane zone (Liotta et al., 1987) . In the dermis, the outermost cells continue to synthesise pigment and are tyrosinase positive. Deeper, the cells round up and become tyrosinase negative. Cells then elongate and differentiate along Schwannian lines (Aso et al., 1986 (Greene et al., 1985) . The histology of the various precursor lesions has also been described in detail (Clark et al., 1984; (Greene et al., 1985) . Histologically, the area shows an increase in the number of melanocytes with some elongation of hyperpigmented rete (Clark et al., 1984 are not arrayed as those in a normal nevus. They may be spindled and a cluster of them is ill-defined. The cells blend with the subjacent lamellar fibroplasia and contribute to its formation. The lamellar fibroplasia is triangular in outline in a two dimensional plane, but doubtless a cone in three dimensions. The lamellar fibroplasia is composed of delicate strands (cross section of a plate if it were seen in three dimensions) of collagen alternating with elongated nuclei. Small granules of melanin may be seen on either side of the nuclei. One gets the impression that the cells of lamellar fibroplasia are derived from epidermal melanocytes that synthesise both collagen and malanin and are differentiating, to some extent along Schwannian lines, for the stacked, platelike structure resembles a Wagner-Meissner corpuscle. Lamellar fibroplasia also strongly suggests parenchymal tumour cell-extracellular matrix interaction. In addition to the connective tissue changes there are always small collections of lymphocytes about the blood vessels of the superficial vascular plexus .
The atypical cells have many antigenic characteristics of 'melanoma cells' seen in Class II and Class III lesions of tumour progression (Aronson et al., 1988) . Some studies of the antigenic profile of tumour progression stages in melanocytic neoplasia show distinctive differences (Holzmann et al., 1987; . Abnormalities of cellular DNA content and random chromosomal abnormalities have been reported in dysplastic nevi (Bergman et al., 1988; Newton et al., 1988; capacity for metastasis could have appeared during the time required for increasing thickness. Thick vertical growth phase tumours have chromosomal abnormalities, usually at chromosomes #1, #6 and #7 and genetic alterations appear in parallel with increasing biological aggressiveness (Nowell, 1989; for lymphocytes and this substance may decrease with progression. Secondly, tumour cells may be dependent, initially, on lymphoid cell products for growth and this dependence decreases with progression. Prehn further suggests that some melanoma cells may lose the power to attract lymphoid cells before they lose growth dependency. Regression may then occur, but other parts of the clone of cells in the vertical growth phase may lose growth dependency along with their ability to attract lymphoid cells. In such an instance, regression may mark a poor prognosis because cells adjacent to the regression can no longer attract lymphocytes and no longer need to do so in order to grow; they have escaped dependence on a part of their microenvironment.
From the foregoing considerations one may derive a list of attributes associated with metastatic disease. Fifteen patients in our data base have had all of the following attributes and all have developed metastatic disease.
(1) A mitotic rate >6mm 2. It is not an objective of this discussion of the analogies between the lesions of tumour progression in diverse neoplastic systems to precisely describe all of the sequential lesions of each system. We would like to show that neoplastic systems are remarkably similar, and these very similarities form a conceptual framework for neoplasia and may indicate research directions of importance in the understanding of some of the basic problems in neoplasia. For example, the initial lesion of neoplasia is a focal benign growth that is probably clonal (Burns, 1989) ; is largely independent of the inductive mechanisms (see following discussion); and is a lesion that usually disappears by a programmed pathway of differentiation. The molecular biology of this primary response to a carcinogen -growth, cessation of growth, and disappearance -has not been extensively investigated. The failure of a given lesion to follow the programmed pathways of an initial lesion (Class IA) -growth, cessation of growth, and disappearance -is the first step in a pathway to cancer; the first step in carcinogenesis. Knowledge of the principles of tumour progression is at the foundation of the present control of mortality due to cancer. Such control is largely based upon knowledge of cancer risk afforded by the existence of some of the Class I lesions. Those individuals identified as having a high risk for any given form of cancer must then have appropriate education, follow-up and therapy. In melanoma, for example, Masri et al. have shown that melanomas diagnosed in follow-up of patients with a family history of melanoma had an average thickness of 0.52 mm, while the melanomas of the index cases of that study had a average thickness of 1.44 mm (Masri, 1990) . We would also like to show that study of the individual lesions appearing relatively early in tumour progression permits biological inference about cancer development that cannot be derived from the study of cells emerging at the end of tumour progression (cells derived from fully developed primary cancers and from metastases).
Class I lesions. The precursor lesions Cutaneous keratinocytic neoplasia Demonstration of reproducible behaviour in the seemingly diverse lesions of neoplasia requires an experimental system . Virtually all human neoplastic systems evolved while the inductive mechanisms are continually active. This is obviously the case when the inductive mechanisms involve light and cutaneous neoplasia. Light impacts upon the skin throughout most of the life span of man. Consequently, observations of coordinated behaviour of cohorts of lesions are confounded by the emergence of sequential crops of lesions at all stages of evolution and regression. If one observes, on a single occasion, a 40 year old red-haired, freckled patient, who has had significant sun exposure, the cutaneous neoplastic lesions of the keratinocytic system will be quite diverse. Benign keratoses, actinic keratoses, and, perhaps, a squamous cell carcinoma will be present. Sorting out the histogenetic and sequential relationships between the many lesions based upon a single observation is likely to be impossible. The problem is similar to the full appreciation of a complex musical canon of eight parts when one hears only the middle of the composition. An (Williams, 1980 (Farber & Sarma, 1987; Farber, 1990) . One of the reasons for using analogy as an investigative tool is to recognise important events by their clear portrayal in one system. The demonstration and study of the disappearance of the initial lesion in neoplasia has been done consistently in the hepatic system and should be regarded as a prototype of behaviour of initial lesions. The initial lesions, in Farber's view, are not pathology but a physiological response, he has termed clonal adaptation (Farber, 1990 (Feinberg et al., 1988) . As a rule the sequential series of qualitatively different polyps is accompanied by progressive increase in size of the lesions. The colonic polyp sequence is easily fitted into the Class IA,IB, and IC scheme of this presentation. The parallels between colorectal cancer development and other neoplastic systems are easily seen. Vogelstein's work has provided, in addition, evidence that progression from the polyp sequence to carcinoma to metastasis is associated with the sequential accumulation of genetic abnormalities (oncogene activation and inactivation of suppressor genes ) (Fearon et al., 1990 Hepatic neoplasia The detailed study of the later steps of cancer development in the rat liver has not been done. The extensive investigations of hepatocarcinogenesis have concentrated on initiation, promotion and the earliest steps of tumour progression; steps preceding cancer. In fact many studies of experimental carcinogenesis seem to treat the appearance of invasive cancer as an end point. The complex events occurring within what we here term Class II and Class III lesions have not been the subject of detailed inquiry in experimental cancers. However, a group of lesions designated as nodules within nodules, while not overtly invasive, does progress to invasive cancer. Consequently, they seem to be analogous with Class II lesions. Transplantation of the lesions designated as nodules within nodules to the spleen of syngeneic animals is followed by progression of the transplanted lesion to overtly invasive cancer (Farber & Sarma, 1987) .
Colonic neoplasia Late adenomas commonly show areas that in other neoplastic systems would be called carcinoma in situ. One may also see, in these late adenomas, areas of extension below the basement membrane zone. Actual growth apparently does not occur in the mesenchyme of the site. As long as such extensions below the basement membrane zone do not extend to the lamina propria, the lesions are not termed carcinoma for no metastases occur (Plaz, 1978) . Such lesions are precise analogies with radial growth phase melanomas. In colonic neoplasia the term carcinoma is not used for lesions that have no potential for metastasis. Obviously such lesions are prototypes of the Class II lesions as discussed in this paper.
Class III lesions. Primary invasive cancer with manifestation of growth in the mesenchyme of the primary site These lesions are the lesions with some potential for metastasis. As a rule the diverse metastatic pathways that seem manifest in melanocytic neoplasia are not discussed at length in other forms of neoplasia. Group, 1991; Sagebiel, 1991 and cervix neoplastic development (Ferenczy & Winkler, 1987; Dupont & Page, 1985; Page & Dupont, 1990 (Nicolson, 1987 This first response to a carcinogen has been termed the initial lesion. The form and behaviour of the initial lesion is the reference for the nature of aberrant form and behaviour in subsequent Class I lesions. The initial lesion is the manifestation of clonal adaptation as described by Farber and progressive state selection as described by Rubin (Farber, 1990; Rubin, 1990 (Nicolson, 1987 (1) The precursor states Cancers develop from precursor conditions that may result in large numbers of atypical cells. Farber has suggested that the initial lesions of neoplastic development (the hepatocyte nodule in hepatocarcinogenesis) are a physiologic response to cellular injury and are protective to the organism; the failure of the initial lesions to differentiate and disappear is the first indication that a pathway toward the development of cellular atypia has been evoked (Farber & Sarma, 1987) . Aberrent growth and the apparance of atypical cells (dysplastic lesions) usually accompany the failure to differentiate: the pathway to cancer has begun. Yuspa has suggested that the process of carcinogenesis requires an alteration in the program of terminal differentiation in addition to aberrent growth control (Yuspa et al., 1988 (Bissell et al., 1982) . The cells of the tumour may then express an environmentally dependent (extracellular matrix) form of cellular inheritance. Harry Rubin considers such changes in tumours as one form of epigenesis, 'the acquisition of heritable characteristics without a covalent change in cellular DNA' (Rubin, 1990) . Such heritable characteristics would not be stable, but dynamic due to a continuum of interation with the extracellular matrix (Rubin et al., 1985) . Vriel In fact, some cancers have no demonstrable abnormalities of oncogenes or tumour suppressor genes and some are strictly diploid (Nicolson, 1987 (Kerbel et al., 1988 (Nicolson, 1987) . Such a last step is probably quite rare.
A list of the events and properties of a complete neoplastic system would be almost endless and similar in magnitude to the events of embryogenesis. There is not enough DNA nor abnormalities of DNA to explain neoplasia. That which is abnormal is not consistent from one neoplasm to the next. The magnitude of the problem is clearly expressed by R.C.
Lewontin in his review of Edelman's book on Topobiology. I quote Lewontin, 'The problem is not one of dimension but of size. The nucleus of the cell of the fruit fly Drosophila, the favourite organism of the ge.neticists has enough DNA to specify the structure of about 5,000 different proteins and about 30 times that much DNA is available to provide spatial and temporal instructions about when the production of proteins by those genes should be turned on and turned
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Figure 4 The pattern of normal nevi in a 22 year old woman is shown. The appearance is characteristic of the initial lesions of melanocytic neoplasia (Class IA lesion). The nevi are small and relatively uniform in colour and outline. The lesions usually differentiate and disappear over the next three decades of life. Figure 5 The clinical presentation of melanocytic nevi with aberrant differentiation and dysplasia in a 30 year old male patient who developed melanoma. The lesions are prototypic for Class IB and IC lesions of melanocytic neoplasia and manifest the beginning of tumour progression. Representative lesions are larger and more irregular in outline and colouration than normal nevi (Class IA). Figures 6 and 7 The development of dysplastic nevi over a 6 year period in a male patient is shown. The patient's grandmother had melanoma and his father has dysplastic nevi. Figure 6 was taken at age 7 and Figure 7 at age 13. Class IB and IC lesions (aberrant differentiation and dysplasia) tend to slowly enlarge and then become indolent. Differentiation and disappearance is uncommon. Figure 8 The photograph illustrates a malignant melanoma in the radial growth phase (Class IIB lesion) arising from a dysplastic nevus. The dysplastic nevus is the upper, irregular, tan-brown part of the lesion. The melanoma is the lower, black area. Class IIB lesions extend into the subjacent mesenchyme but do not metastasise. The cells in the dermis of radial growth phase melanomas usually show individual cells or small nests of cells surrounded by an intact basement membrane zone. Figure 9 A malignant melanoma that has -evolved from the radial to the vertical growth phase is shown. The picture is representative of a melanoma that has progressed to metastatic competence as manifested by the ability to grow in the mesenchyme of the primary site (Class III lesion). The upper centre and right portion of the photograph illustrate the radial growth phase. The centre shows an area of regression. The black nodule on the left is the vertifical growth phase partially surrounded by a remnant of a dysplastic nevus.
off. But this is simply too little, by many orders of magnitude, to tell every cell when it should divide, exactly where it should move next, and what cellular structures it should produce, over the entire developmental history of the fly. One needs to imagine an instruction manual that will tell every New Yorker when to wake up, where to go, and what to do, hour by hour, day by day, for the next century. There is just not enough DNA to go around' (Lewontin, 1989) . To explain metazoan life or explain neoplasia in metazoan life.
Finally, it must be stated that tumour progression is not some engima hidden in the jargon of pathologists or molecular biologists. The lesions are not only visible, but their very appearance attests to their behaviour and, thus, to some aspect of their nature. The symmetry, differentiation and disappearance of initial lesions may be observed. The abnormalcy of aberrant differentiation is manifest as a large, asymmetrical nevus. The temporally unrestricted growth of intermediate lesions may be historically confirmed. Acquisition of competence for metastasis is reflected in changes in form of the primary cancer. All of the events of tumour progression are exceedingly complicated at the molecular level; at the level of the cell and the organism, however, tumour progression can be visualised and conceptualised. The accompanying illustrations permit one to visualise the sequence of lesional tumour progression events in human melanocytic neoplasia (Figures 4-9) .
